0001209191-22-038595.txt : 20220621 0001209191-22-038595.hdr.sgml : 20220621 20220621204852 ACCESSION NUMBER: 0001209191-22-038595 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220616 FILED AS OF DATE: 20220621 DATE AS OF CHANGE: 20220621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCMANUS MICHAEL A JR CENTRAL INDEX KEY: 0001051997 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 221029751 MAIL ADDRESS: STREET 1: 241-02 NORTHERN BLVD CITY: DOUGLASTON STATE: NY ZIP: 11362 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 21 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-16 0 0001000694 NOVAVAX INC NVAX 0001051997 MCMANUS MICHAEL A JR C/O NOVAVAX, INC. 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 1 0 0 0 Common Stock 2022-06-16 4 M 0 700 A 10101 D Restricted Stock Units 2022-06-16 4 M 0 700 0.00 D Common Stock 700 0 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. In connection with the reporting person's departure from the Board of Directors (the "Board"), the Board accelerated the vesting of 700 RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), to June 16, 2022 from June 17, 2022. /s/ John A. Herrmann III, Attorney-in-Fact 2022-06-21